Spero Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $40.3M | $52.9M | $76.3M | $109.1M | $112.6M | $85.2M | $29.7M | $34.1M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $67.3M | $107.3M | $131.2M | $113.6M | $157.9M | $139.1M | $95.4M | $124.2M |
| Property, Plant & Equipment | — | $0 | $2.0K | $368.0K | $1.0M | $1.7M | $2.3M | $2.9M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $68.9M | $110.5M | $182.4M | $124.8M | $171.1M | $153.5M | $106.1M | $129.0M |
| Liabilities | ||||||||
| Accounts Payable | $693.0K | $7.3M | $1.4M | $617.0K | $1.1M | $1.2M | $4.1M | $3.6M |
| Total Current Liabilities | $8.9M | $49.1M | $37.2M | $21.6M | $18.7M | $14.3M | $26.7M | $12.3M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $9.9M | $64.4M | $75.5M | $48.9M | $82.8M | $21.4M | $31.5M | $13.2M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-451.1M | $-459.6M | $-391.1M | $-413.9M | $-367.5M | $-277.7M | $-199.4M | $-138.5M |
| Total Stockholders' Equity | $59.0M | $46.1M | $106.9M | $75.9M | $88.3M | $132.0M | $74.6M | $115.5M |